Benjamin T. Kile
Hoofd Techniek/Wetenschap/O&O bij MuriGen Pty Ltd.
Profiel
Benjamin T.
Kile is currently the Chief Scientific Officer at MuriGen Pty Ltd.
He previously worked at Baylor College of Medicine as a Principal.
Actieve functies van Benjamin T. Kile
| Bedrijven | Functie | Begin |
|---|---|---|
MuriGen Pty Ltd.
 MuriGen Pty Ltd. Pharmaceuticals: MajorHealth Technology MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia. | Hoofd Techniek/Wetenschap/O&O | 23-04-2010 |
Eerdere bekende functies van Benjamin T. Kile
| Bedrijven | Functie | Einde |
|---|---|---|
| Baylor College of Medicine | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
MuriGen Pty Ltd.
MuriGen Pty Ltd. Pharmaceuticals: MajorHealth Technology MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia. | Health Technology |
